Abaxis (ABAX) Gets U.S. FDA 501(k) Clearance to Market CRP when Used In Conjunction with Piccolo Xpress POC Analyzer

January 21, 2010 7:44 AM EST Send to a Friend
Abaxis, Inc. (NASDAQ: ABAX) today announced that the U.S. Food and Drug Administration (FDA) has granted 510K marketing clearance of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login